From Vision to Victory: The Stilla-Bio-Rad Journey

A milestone etched in steel, heart, and science!

As of June 30th, Stilla Technologies is now part of Bio-Rad Laboratories – NYSE: BIO.
What a ride. What an offshore racing. What an accomplishment. What an honor to have been part of this exceptional adventure from the factory floor to the stars.

When Rémi Dangla called on Maison MGA to imagine and build the Nio®, now QX700™️, we knew we were stepping into something extraordinary. But none of us expected the depth of what followed:

A true alliance of science, purpose, and manufacturing excellence.
A living proof that France can still design, industrialize and scale deep tech for global health, right here, at home.
A human odyssey, built on trust, grit and that Stillian spark.

From the first prototypes to the ribbon-cutting of our MGA MedTech 4.0 factory in Mably, from wild ideas on paper to real instruments in labs worldwide, from challenge to challenge, we held the line. Together.
And today, with Bio-Rad by STILLA’s side, the impact will be nothing short of worldwide.

This is not an end.
This is a powerful new beginning.

The future of health deserves it. And we’re proud to help build it, with French hands, bright minds and bold hearts. Congrats to all who made this possible! Including Sébastien Bernay, Stephane Buttin, Etienne Fradet, Clémence D., Dominique Ravot and many more!

Let’s keep making history. Together.